Merck Korea to launch anti-diabetic drug "Glucophage XR"
Published: 2006-04-04 06:55:00
Updated: 2006-04-04 06:55:00
Merck Korea, a subsidiary of German Merck, announced the market launching plan for an anti-diabetic drug called "Glucophage XR sustained tablet" in April, which was a sustained metformin tablet taking once 4 tablets (2000mg) a day in maximum.
Merck Korea said that the new tablet showed 24 hou...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
